Anne Wojcicki's 23andMe brought innovation to the personal genetics market, a move fraught with regulatory and market uncertainties. By making genetic testing accessible and empowering individuals with information about their health and ancestry, Wojcicki navigated through complex regulatory landscapes. This case underlines the importance of innovation in not only surviving but thriving in uncertain markets.
- Log in or register to contribute
Contribute to three or more articles across any domain to qualify for the Contributor badge. Please check back tomorrow for updates on your progress.
